Intrinsic Value

Not Available for CODX

There is not enough data to reliably calculate the intrinsic value for Co-Diagnostics Inc.

Do our valuations actually work? See backtest results .

Alternatives to CODX

Fundamental Analysis

What Co-Diagnostics Does

Health Care

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 115 full-time employees. The company went IPO on 2017-07-12. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA).

Headquarters
United States of America US
Employees
132
IPO date
Jul 12, 2017
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Co-Diagnostics Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

CODX Insider Trading
Buy and sell transactions by insiders